Literature DB >> 15591070

Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells.

Miren Kerkmann1, Lilian T Costa, Christine Richter, Simon Rothenfusser, Julia Battiany, Veit Hornung, Judith Johnson, Steffen Englert, Thomas Ketterer, Wolfgang Heckl, Stefan Thalhammer, Stefan Endres, Gunther Hartmann.   

Abstract

Plasmacytoid dendritic cells (PDC) represent a highly specialized immune cell subset that produces large quantities of the anti-viral cytokines type I interferons (IFN-alpha and IFN-beta) upon viral infection. PDC employ a member of the family of toll-like receptors, TLR9, to detect CpG motifs (unmethylated CG dinucleotides in certain base context) present in viral DNA. A certain group of CpG motif-containing oligodeoxynucleotides (CpG ODN), CpG-A, was the first synthetic stimulus available that induced large amounts of interferon-alpha (IFN-alpha) in PDC. However, the mechanism responsible for this activity remained elusive. CpG-A is characterized by a central palindrome and poly(G) at the 5' and 3' end. Here we demonstrate that CpG-A self-assembles to higher order tertiary structures via G-tetrad formation of their poly(G) motifs. Spontaneous G-tetrad formation of CpG-A required the palindrome sequence allowing structure formation in a physiological environment. Once formed, G-tetrad-linked structures were stable even under denaturing conditions. Atomic force microscopy revealed that the tertiary structures formed by CpG-A represent nucleic acid-based nanoparticles in the size range of viruses. Similarly sized preformed polystyrene nanoparticles loaded with a CpG ODN that is otherwise weak at inducing IFN-alpha (CpG-B) gained the potency of CpG-A to induce IFN-alpha. Higher ODN uptake in PDC was not responsible for the higher IFN-alpha-inducing activity of CpG-A or of CpG-B-coated nanoparticles as compared with CpG-B. Based on these results we propose a model in which the spatial configuration of CpG motifs as particle is responsible for the virus-like potency of CpG-A to induce IFN-alpha in PDC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591070     DOI: 10.1074/jbc.M410868200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  3'poly-G-tailed ODNs inhibit F-spondin to induce cell death and neurite retraction in rat embryonic neurons.

Authors:  Yung-Chih Cheng; Tai-An Chen; Chih-Yuan Chen; Chi-Ming Liang; Shu-Mei Liang
Journal:  Mol Neurobiol       Date:  2012-05-17       Impact factor: 5.590

2.  Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides.

Authors:  Klaus Zwiorek; Carole Bourquin; Julia Battiany; Gerhard Winter; Stefan Endres; Gunther Hartmann; Conrad Coester
Journal:  Pharm Res       Date:  2007-10-03       Impact factor: 4.200

Review 3.  Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history.

Authors:  Patricia Fitzgerald-Bocarsly; Jihong Dai; Sukhwinder Singh
Journal:  Cytokine Growth Factor Rev       Date:  2008-01-11       Impact factor: 7.638

4.  Sequence independent interferon-alpha induction by multimerized phosphodiester DNA depends on spatial regulation of Toll-like receptor-9 activation in plasmacytoid dendritic cells.

Authors:  Tobias Haas; Frank Schmitz; Antje Heit; Hermann Wagner
Journal:  Immunology       Date:  2008-11-15       Impact factor: 7.397

5.  DNA-polymer conjugates for immune stimulation through Toll-like receptor 9 mediated pathways.

Authors:  Eric A Levenson; Kristi L Kiick
Journal:  Acta Biomater       Date:  2013-12-06       Impact factor: 8.947

6.  Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.

Authors:  Alexandre de Titta; Marie Ballester; Ziad Julier; Chiara Nembrini; Laura Jeanbart; André J van der Vlies; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

7.  TLR2 joins the interferon gang.

Authors:  Franz Bauernfeind; Veit Hornung
Journal:  Nat Immunol       Date:  2009-11       Impact factor: 25.606

8.  Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system.

Authors:  Liang Cheng; Zheng Zhang; Guangming Li; Feng Li; Li Wang; Liguo Zhang; Sandra M Zurawski; Gerard Zurawski; Yves Levy; Lishan Su
Journal:  Vaccine       Date:  2017-09-25       Impact factor: 3.641

Review 9.  Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.

Authors:  Petar S Lenert
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

10.  A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.

Authors:  N A Libri; S J Barker; W M C Rosenberg; A E Semper
Journal:  J Viral Hepat       Date:  2009-02-24       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.